Condensed Consolidated and Combined Statements of Income (Unaudited) - USD ($) shares in Millions, $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Revenue	$ 4,822	$ 4,576	$ 14,346	$ 13,403
Gross profit	1,935	1,773	5,766	5,247
Selling, general, and administrative	996	908	3,130	2,747
Research and development	322	260	890	755
Total operating expenses	1,318	1,168	4,020	3,502
Operating income	617	605	1,746	1,745
Interest and other financial charges – net	138	2	411	18
Non-operating benefit (income) costs	(94)	(1)	(332)	(4)
Other (income) expense – net	(63)	(18)	(85)	(63)
Income from continuing operations before income taxes	636	622	1,752	1,794
Benefit (provision) for income taxes	(250)	(129)	(550)	(412)
Net income from continuing operations	386	493	1,202	1,382
Income (loss) from discontinued operations, net of taxes	(4)	0	(4)	12
Net income	382	493	1,198	1,394
Net (income) loss attributable to noncontrolling interests	(7)	(6)	(33)	(32)
Net income attributable to GE HealthCare	375	487	1,165	1,362
Deemed preferred stock dividend of redeemable noncontrolling interest	0	0	(183)	0
Net income attributable to GE HealthCare common stockholders	$ 375	$ 487	$ 982	$ 1,362
Earnings per share from continuing operations attributable to GE HealthCare common stockholders:
Basic (in dollars per share)	$ 0.83	$ 1.07	$ 2.17	$ 2.97
Diluted (in dollars per share)	0.83	1.07	2.16	2.97
Earnings per share attributable to GE HealthCare common stockholders:
Basic (in dollars per share)	0.82	1.07	2.16	3.00
Diluted (in dollars per share)	$ 0.82	$ 1.07	$ 2.15	$ 3.00
Weighted-average number of shares outstanding:
Basic (in shares)	455	454	455	454
Diluted (in shares)	458	454	458	454
Products
Revenue	$ 3,186	$ 3,012	$ 9,530	$ 8,702
Cost of revenue	2,076	1,995	6,197	5,825
Services
Revenue	1,636	1,564	4,816	4,701
Cost of revenue	$ 811	$ 808	$ 2,383	$ 2,331